Skip to main content

Advertisement

Log in

Factors Leading to Improved Results for Endoscopic Stenting for Metastatic Antropyloric Adenocarcinoma. A Comparison with Gastrojejunostomy

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

ABSTRACT

Background

Controversies exist about the optimal palliative management for patients with metastatic antropyloric adenocarcinoma. The aim of this study was to analyse the clinical outcome for patients with gastric outlet obstruction syndrome and metastatic antropyloric adenocarcinoma, who underwent endoscopic stenting or open gastrojejunostomy, in a prospective not randomised study.

Material

The clinical course and costs for 70 patients who had endoscopic stenting and for 30 patients who had in the same period a gastrojejunostomy for gastric outlet obstruction syndrome due to metastatic adenocarcinoma of the antropyloric region were prospectively analysed.

Results

Hospital stay and time to resume oral feeding was shorter in patients who had endoscopic stenting (p < 0.05). Overall costs for endoscopic stenting were lower than those for gastrojejunostomy (11,000 versus 21,000 euros). Comparing patients who survived more than 6 months, costs between endoscopic stenting and gastrojejunostomy were similar (21,000 versus 22,000 euros).

Conclusions

Endoscopic placement of metallic stents offers an effective therapy in patients with advanced primay adenocarcinoma of the antropyloric region and poor general conditions. In patients with longer life expectancy, surgical gastroenterostomy has still a major role. In contrast to previous reports, costs for endoscopic stenting are similar to those of gastrojejunostomy in patients with longer life expectancy. Laparoscopic gastrojejunostomy has the theoretical advantage to reduce these costs with a less invasive procedure. Results for endoscopic stenting have improved significantly in recent years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hunday SA, Philips JL, Menck HR “The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy. Fifth edition American Joint Committee on cancer staging, proximal disease and different disease” Cancer 2000; 88:921–932

    Article  Google Scholar 

  2. Fiori E, Lamazza A, Sterpetti AV: “Endoscopic stenting and gastrojejunostomy for gastric outlet obstruction due to unresectable antropyloric adenocarcinoma: final results of a prospective study and review of the literature. Am J Surg 2013;206: 210–217

    Article  PubMed  Google Scholar 

  3. Adler DG, Baron TH “Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients”. Am J Gastroenterol 2002; 97:72–78

    Article  PubMed  Google Scholar 

  4. Lee JM, Han YM, Kim CS et al. “Fluoroscopic-guided covered metallic stent placement for gastric outlet obstruction and post-operative gastroenterostomy anastomotic stricture”. Clin Radiol 2001; 56: 560–567

    Article  CAS  PubMed  Google Scholar 

  5. Havemann MC, Adamsen S, Wøjdemann M.” Malignant gastric outlet obstruction managed by endoscopic stenting: a prospective single-centre study”. Scand J Gastroenterol. 2009;44:248–51.

    Article  PubMed  Google Scholar 

  6. Jeurnink SM, van Eijck CH, Steyerberg EW et al.: “Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review” BMC Gastroenterology 2007 7:18

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ly J, O’Grady G, Mittal A et al.:” A systematic review of the methods to palliate malignant gastric obstruction” Surg Endosc 2010; 24: 290–297

    Article  PubMed  Google Scholar 

  8. Dormann A, Meisner S, Verin N et al. “Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness”.Endoscopy. 2004;36(6):543–50.

    Article  CAS  PubMed  Google Scholar 

  9. Kim CG, Choi IJ, Lee JY et al. “Covered versus uncovered self-expandable metallic stents for palliation of malignant pyloric obstruction in gastric cancer patients: a randomized, prospective study”. Gastrointest Endosc. 2010;72:25–32.

    Article  PubMed  Google Scholar 

  10. Kim CG, Park SR, Choi IJ et al. “Effect of chemotherapy on the outcome of self-expandable metallic stents in gastric cancer patients with malignant outlet obstruction. Endoscopy. 2012;44:807–12.

    Article  CAS  PubMed  Google Scholar 

  11. Schwarz RE: “Current status of management of malignant disease: Current management of gastric cancer” J Gastrointest Surg 2015; 19: 782–788

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio V. Sterpetti.

Ethics declarations

Funding

No fund was received for this paper.

Conflicts of Interest

None of the authors has conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fiori, E., Sterpetti, A.V., De Cesare, A. et al. Factors Leading to Improved Results for Endoscopic Stenting for Metastatic Antropyloric Adenocarcinoma. A Comparison with Gastrojejunostomy. J Gastrointest Surg 20, 1802–1806 (2016). https://doi.org/10.1007/s11605-016-3236-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-016-3236-6

Keywords

Navigation